Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wafer-level burn-in may be Aehr Test Systems� technical edge, yet investors often just want to know who is buying stock, how margins move, or whether new EV design wins are material. That information is scattered across hundreds of pages and several form types—especially when you search for “Aehr Test Systems SEC filings explained simply.� The same hunt includes the “Aehr Test Systems quarterly earnings report 10-Q filing� and “Aehr Test Systems insider trading Form 4 transactions,� turning routine research into a time drain.
Stock Titan’s platform removes that friction. Our AI-powered summaries break down every section of the annual report—search “Aehr Test Systems annual report 10-K simplified� and jump straight to key risk factors. Receive real-time alerts for “Aehr Test Systems Form 4 insider transactions real-time,� so you see executive stock moves minutes after they hit EDGAR. New design-win announcements? We flag them the moment the company files an 8-K, giving you “Aehr Test Systems 8-K material events explained� in plain English.
Whether you’re comparing backlog growth across quarters or vetting “Aehr Test Systems executive stock transactions Form 4,� our coverage spans every disclosure type:
- AI-generated “Aehr Test Systems earnings report filing analysis� with side-by-side trend charts
- Guided walkthroughs for “understanding Aehr Test Systems SEC documents with AI�
- Red-lined changes in the preliminary “Aehr Test Systems proxy statement executive compensation� so pay packages are clear
No more digging through PDFs—our expert analysis, real-time updates, and full Form library put the critical data points in context, letting you act before the market does.
Form 4 filing � Aehr Test Systems (AEHR) submitted 07/03/2025 discloses insider transactions by Vernon Rogers, Executive Vice President of Sales & Marketing.
- 13,351 common shares (Transaction Code A) were acquired on 07/02/2025 through restricted stock unit (RSU) vesting at $0 cost. Footnote 1 states 1/16 of the award vests every three months.
- An additional 1,614 common shares (Code A) vested on the same date at $0 cost; 25% of this award vested immediately, with the remainder vesting quarterly over three years (Footnote 2).
- 218 shares (Code F) were withheld at $15.13 per share to satisfy tax-withholding obligations (Footnote 3); this is not an open-market sale.
- After all transactions, Mr. Rogers directly owns 70,390 AEHR shares, which include unvested RSUs (Footnote 4). The filing notes he previously received 6,486 shares upon termination of the company’s ESOP on 04/25/2025.
No derivative securities were reported. The filing reflects routine equity compensation vesting rather than discretionary market purchases or sales.
Form 4 overview: On 07/02/2025, Alistair N. Sporck, Vice-President of the Contractor Business Unit at Aehr Test Systems (AEHR), reported several equity transactions.
- Restricted Stock Units granted: 9,253 RSUs with quarterly vesting over four years (1/16 per quarter) and 2,276 RSUs with 25% immediate vesting and the balance vesting quarterly over three years. Both grants were recorded at a cost basis of $0.
- Tax-withholding transaction: 305 shares were automatically withheld at $15.13 to cover taxes on vested RSUs; this is classified as a disposition code “F� and does not represent an open-market sale.
- Post-transaction ownership: Sporck now directly owns 34,120 common shares and indirectly controls 3,993 shares through a trust.
- The filing notes an additional 936 shares received on 04/25/2025 from the termination of the company’s ESOP, included in the total.
No derivative securities were reported. The transactions reflect routine executive compensation and tax-withholding activity, with no cash proceeds to the insider and no change to the company’s share count.
Form 4 filing overview � AEHR Test Systems (AEHR)
Executive Vice President Alberto Salamone reported two equity transactions dated 02 July 2025:
- Acquisition: 18,126 common shares were acquired at $0.00, indicating the vesting/grant of restricted stock units (RSUs). Following this line item, his direct ownership increased to 80,976 shares.
- Tax-withholding disposition: 2,441 shares were automatically withheld at $15.13 per share (transaction code “F�). This was not an open-market sale but satisfied payroll tax obligations tied to the RSU vesting.
Ending beneficial ownership: 78,535 common shares, which still includes unvested RSUs referenced in footnote 3.
The RSU schedule (footnote 1) states that 25 % vests immediately, with the remaining 75 % vesting quarterly over three years, aligning Salamone’s incentives with long-term shareholder value.
No derivative securities were reported. The filing signals continued insider equity exposure with only routine, non-discretionary share withholding. There is no indication of open-market selling pressure.
Form 4 overview � Aehr Test Systems (AEHR)
On 07/02/2025, Executive Vice President Alberto Salamone reported the acquisition of 6,609 shares of common stock via a restricted stock unit (RSU) grant recorded at $0 cost. After the award, his direct beneficial ownership rose to 62,850 shares, a total that includes unvested RSUs.
The explanatory note states that one-sixteenth of the RSU award vests every three calendar months, provided employment is maintained. No sales or derivative transactions were disclosed, and Table II shows no option activity. The filing therefore reflects routine equity compensation, not an open-market transaction, and does not by itself signal a directional view on AEHR’s valuation.
FAQ
What is the current stock price of Aehr Test Sys (AEHR)?
What is the market cap of Aehr Test Sys (AEHR)?
